Deracoxib-d4 is a deuterium-labeled derivative of Deracoxib, a selective COX-2 inhibitor primarily employed in veterinary medicine. By inhibiting the COX-2 enzyme, Deracoxib-d4 effectively reduces prostaglandin synthesis, thus controlling pain and inflammation following soft tissue surgeries in dogs. This compound demonstrates minimal COX-1 inhibition, lowering the likelihood of gastrointestinal complications. Additionally, Deracoxib-d4 exhibits anti-tumor properties, inducing cell cycle arrest and apoptosis in various canine tumors, including osteosarcoma and transitional cell carcinoma of the bladder.
Deracoxib-d4 is a deuterium-labeled derivative of Deracoxib, a selective COX-2 inhibitor primarily employed in veterinary medicine. By inhibiting the COX-2 enzyme, Deracoxib-d4 effectively reduces prostaglandin synthesis, thus controlling pain and inflammation following soft tissue surgeries in dogs. This compound demonstrates minimal COX-1 inhibition, lowering the likelihood of gastrointestinal complications. Additionally, Deracoxib-d4 exhibits anti-tumor properties, inducing cell cycle arrest and apoptosis in various canine tumors, including osteosarcoma and transitional cell carcinoma of the bladder.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
